$0.03
(0.60%)
4.18%
Create an alert
Stocks and Shares ISAMaravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Company Information
About this company
Key people
Robert Andrew Eckert
Independent Chairman of the Board
Bernd Brust
Chief Executive Officer, Director
Rajesh J. Asarpota
Chief Financial Officer
Kurt Oreshack
Executive Vice President, General Counsel, Secretary
Christine Dolan
Executive Vice President, General Manager - Cygnus Technologies
Sean L. Cunningham
Director
Luke Joseph Marker
Director
Constantine S. Mihas
Director
John A. Deford
Independent Director
Click to see more
Key facts
- Shares in issue147.51m
- EPICMRVI
- ISINUS56600D1072
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$1.25bn
- Employees416
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.